{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:54:56Z","timestamp":1791262496934,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22037004"],"award-info":[{"award-number":["22037004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110553","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:51:22Z","timestamp":1789721482000},"page":"110553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A tumor-targeting strategy based on covalent aptamer-carborane conjugates"],"prefix":"10.1016","volume":"182","author":[{"given":"Xiaolu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaokang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110553_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1570163812666150602144310","article-title":"Targeted Cancer therapy: the next generation of Cancer treatment","volume":"12","author":"Troy","year":"2015","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.bioorg.2026.110553_bb0010","doi-asserted-by":"crossref","unstructured":"Sauerwein, W. A. G. Principles and Roots of Neutron Capture Therapy. In Neutron Capture Therapy: Principles and Applications, Sauerwein, W.; Wittig, A.; Moss, R.; Nakagawa, Y., Springer, Berlin, Heidelberg, 2012, pp. 1\u201316. doi:https:\/\/doi.org\/10.1007\/978-3-642-31334-9_1.","DOI":"10.1007\/978-3-642-31334-9_1"},{"key":"10.1016\/j.bioorg.2026.110553_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.apradiso.2013.11.109","article-title":"Critical review, with an optimistic outlook, on boron neutron capture therapy (BNCT)","volume":"88","author":"Moss","year":"2014","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.bioorg.2026.110553_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3579742","article-title":"The radiation biology of boron neutron capture therapy","volume":"151","author":"Coderre","year":"1999","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bioorg.2026.110553_bb0025","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/med.21964","article-title":"Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment","volume":"43","author":"Coghi","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110553_bb0030","first-page":"251","article-title":"First human clinical trial of melanoma neutron capture: diagnosis and therapy","volume":"165","author":"Mishima","year":"1989","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.bioorg.2026.110553_bb0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijrobp.2010.02.031","article-title":"L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a phase I study","volume":"80","author":"Kankaanranta","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioorg.2026.110553_bb0040","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/jm00316a042","article-title":"Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds","volume":"10","author":"Soloway","year":"1967","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110553_bb0045","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0360-3016(94)90479-0","article-title":"Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy","volume":"28","author":"Hatanaka","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioorg.2026.110553_bb0050","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/cac2.12582","article-title":"Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT","volume":"44","author":"Rolf","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioorg.2026.110553_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.217555","article-title":"Achievements, challenges, and perspectives in the design of boron delivery agents for neutron capture therapy","volume":"553","author":"Yang","year":"2026","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110553_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40880-018-0299-7","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioorg.2026.110553_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2019.213139","article-title":"Boron agents for neutron capture therapy","volume":"405","author":"Hu","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110553_bb0070","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1016\/j.jorganchem.2007.06.001","article-title":"Reactions of oxonium derivatives of [B12H12]2\u2212 with amines: synthesis and structure of novel B12-based ammonium salts and amino acids","volume":"692","author":"Semioshkin","year":"2007","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110553_bb0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-328X(99)00085-6","article-title":"Identification, development, synthesis and evaluation of boron-containing nucleosides for neutron capture therapy","volume":"581","author":"Soloway","year":"1999","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110553_bb0080","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/zaac.200400064","article-title":"Conjugation of the closo-borane mercaptoundecahydrododecaborate (BSH) to a tumour selective peptide","volume":"630","author":"Mier","year":"2004","journal-title":"Z. Anorg. Allg. Chem."},{"key":"10.1016\/j.bioorg.2026.110553_bb0085","first-page":"141","article-title":"Recent developments in boron neutron capture therapy (BNCT) driven by nanotechnology","volume":"1","author":"Zhu","year":"2007","journal-title":"Curr. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110553_bb0090","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.apradiso.2009.03.018","article-title":"Disposition of TF-PEG-liposome-BSH in tumor-bearing mice","volume":"67","author":"Ito","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.bioorg.2026.110553_bb0095","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/molecules24234229","article-title":"Aptamers: a review of their chemical properties and modifications for therapeutic application","volume":"24","author":"Adachi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110553_bb0100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110553_bb0105","article-title":"Advances in screening and development of therapeutic aptamers against cancer cells","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2026.110553_bb0110","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1021\/jacs.3c00841","article-title":"Aptamer-based targeted delivery of functional nucleic acids","volume":"145","author":"Xie","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110553_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136673","article-title":"A synthetic aptamer-drug adduct for targeted liver cancer therapy","volume":"10","author":"Trinh","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.110553_bb0120","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bbagen.2016.12.015","article-title":"G-quadruplex oligonucleotide AS1411 AS a cancer-targeting agent: uses and mechanisms","volume":"1861","author":"Bates","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bioorg.2026.110553_bb0125","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1038\/s41598-019-44388-9","article-title":"Aptamer-based targeted delivery of a G-quadruplex ligand in cervical cancer cells","volume":"9","author":"Carvalho","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110553_bb0130","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.274.37.26369","article-title":"Antiproliferative activity of G-rich oligonucleotides correlates with protein binding","volume":"274","author":"Bates","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110553_bb0135","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1124\/mol.109.055947","article-title":"Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells","volume":"76","author":"Soundararajan","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110553_bb0140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jiec.2018.07.017","article-title":"Cancer-targeted photothermal therapy using aptamer-conjugated gold nanoparticles","volume":"67","author":"Hong","year":"2018","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.bioorg.2026.110553_bb0145","doi-asserted-by":"crossref","first-page":"31227","DOI":"10.1021\/acsomega.0c04605","article-title":"Synthesis and application of AS1411-functionalized gold nanoparticles for targeted therapy of gastric cancer","volume":"5","author":"Zhang","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110553_bb0150","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1039\/C7TB02218B","article-title":"Stable polyvalent aptamer-conjugated NIR fluorescent nanocomposite for cancer imaging and therapy","volume":"5","author":"Zhu","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioorg.2026.110553_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1217769","article-title":"Anti-nucleolin aptamer AS1411: an advancing therapeutic","volume":"10","author":"Van den Avont","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2026.110553_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12951-022-01240-z","article-title":"Progress in cancer drug delivery based on AS1411 oriented nanomaterials","volume":"20","author":"Tong","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioorg.2026.110553_bb0165","doi-asserted-by":"crossref","unstructured":"Oney, S.; Lam, R. T. S.; Bompiani, K. M.; Blake, C. M.; Quick, G.; Heidel, J. D.; Liu, J. Y.; Mack, B, C.; Davis, M. E.; Leong, K. W.; Sullenger, B. A. Development of universal antidotes to control aptamer activity. Nat. Med. 2009, 15, 1224\u20131228. doi:https:\/\/doi.org\/10.1038\/nm.1990.","DOI":"10.1038\/nm.1990"},{"key":"10.1016\/j.bioorg.2026.110553_bb0170","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1002\/ange.201204970","article-title":"Rhodium (III)-catalyzed intramolecular annulation through C\u2013H activation: total synthesis of (\u00b1)-antofine, (\u00b1)-septicine, (\u00b1)-tylophorine, and rosettacin","volume":"51","author":"Xu","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.110553_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0162-0134(00)00222-1","article-title":"A new approach for the synthesis of isonitrile carborane derivatives: ligands for metal based boron neutron capture therapy (BNCT) and boron neutron capture synovectomy (BNCS) agents","volume":"85","author":"Valliant","year":"2001","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2026.110553_bb0180","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/ange.200806223","article-title":"One-pot approach to well-defined biomolecular assemblies by orthogonal Chemoselective ligations","volume":"48","author":"Galibert","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.110553_bb0185","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.1021\/ja904767k","article-title":"Construction of highly reactive probes for abasic site detection by introduction of an aromatic and a guanidine residue into an aminooxy group","volume":"131","author":"Kojima","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110553_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167211","article-title":"AS1411 binds to nucleolin via its parallel structure and disrupts the exos-miRNA-27a-mediated reciprocal activation loop between glioma and astrocytes","volume":"1870","author":"Sun","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bioorg.2026.110553_bb0195","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3390\/molecules30081673","article-title":"Exploring the G-quadruplex formation of AS1411 derivatives","volume":"30","author":"Louren\u00e7o","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110553_bb0200","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/jcs.112.6.761","article-title":"Structure and functions of nucleolin","volume":"112","author":"Ginisty","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bioorg.2026.110553_bb0205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2407-6-197","article-title":"Met-independent hepatocyte growth factor-mediated regulation of cell adhesion in human prostate cancer cells","volume":"6","author":"Tate","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2026.110553_bb0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(03)00450-6","article-title":"Midkine and pleiotrophin in neural development and cancer","volume":"204","author":"Kadomatsu","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.110553_bb0215","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00432-014-1587-5","article-title":"Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands","volume":"140","author":"Fujiki","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110553_bb0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00018-022-04300-7","article-title":"Nucleolin: a cell portal for viruses, bacteria, and toxins","volume":"79","author":"Tonello","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2026.110553_bb0225","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/cancers10100390","article-title":"Druggable Nucleolin identifies breast tumours associated with poor prognosis that exhibit different biological processes","volume":"10","author":"Nguyen","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110553_bb0230","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbrc.2013.08.076","article-title":"Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of CRC","volume":"440","author":"Hammoudi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2026.110553_bb0235","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/apm.12131","article-title":"Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer","volume":"121","author":"Qiu","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.bioorg.2026.110553_bb0240","article-title":"Prognostic significance of endothelial nucleolin and CD31 in NSCLC","volume":"8","author":"Zhao","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.110553_bb0245","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.20011053","article-title":"Nucleolin as activator of HPV18 oncogene transcription in cervical cancer","volume":"196","author":"Grinstein","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2026.110553_bb0250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biochi.2015.03.023","article-title":"The roles of nucleolin subcellular localization in cancer","volume":"113","author":"Berger","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2026.110553_bb0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yexmp.2009.01.004","article-title":"Discovery and development of AS1411 AS a novel cancer treatment","volume":"86","author":"Bates","year":"2009","journal-title":"Exp. Mol. Pathol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:29:09Z","timestamp":1791260949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S0045206826010898"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110553","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A tumor-targeting strategy based on covalent aptamer-carborane conjugates","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110553"}}